Compass Therapeutics, Inc. (CMPX)
NASDAQ: CMPX · Real-Time Price · USD
5.53
-0.01 (-0.18%)
At close: Dec 5, 2025, 4:00 PM EST
5.52
-0.01 (-0.18%)
After-hours: Dec 5, 2025, 6:29 PM EST
Compass Therapeutics Market Cap
Compass Therapeutics has a market cap or net worth of $983.58 million as of December 5, 2025. Its market cap has increased by 403.43% in one year.
Market Cap
983.58M
Enterprise Value
773.55M
1-Year Change
403.43%
Ranking
Category
Stock Price
$5.53
Market Cap Chart
Since April 5, 2021, Compass Therapeutics's market cap has increased from $435.34M to $983.58M, an increase of 125.93%. That is a compound annual growth rate of 19.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 983.58M | 393.01% |
| Dec 31, 2024 | 199.50M | 0.34% |
| Dec 29, 2023 | 198.83M | -68.61% |
| Dec 30, 2022 | 633.47M | 105.02% |
| Dec 31, 2021 | 308.98M | -29.02% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |